CHEK2 mutation and hereditary breast cancer

被引：14

作者：

Narod, Steven A. ^{[1
]}

Lynch, Henry T.

机构：

[1] Ctr Res Womens Hlth, Toronto, ON, Canada

[2] Creighton Univ, Sch Med, Omaha, NE USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 01期

关键词：

TUMOR CHARACTERISTICS; CHEK2-ASTERISK-1100DELC; 1100DELC; FAMILIES; ALLELE; BRCA1; RISK;

D O I：

10.1200/JCO.2006.08.8229

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：6 / 7

页数：2

共 11 条

[1]

CYBULSKI C, BREAST CANC RES TREA

[2]

CHEK2-positive breast cancers in young Polish women [J].

Cybulski, Cezary ;

Gorski, Bohdan ;

Huzarski, Tomasz ;

Byrski, Tomasz ;

Gronwald, Jacek ;

Debniak, Tadeusz ;

Wokolorczyk, Dominika ;

Jakubowska, Anna ;

Kowalska, Elzbieta ;

Oszurek, Oleg ;

Narod, Steven A. ;

Lubinski, Jan .

CLINICAL CANCER RESEARCH, 2006, 12 (16) :4832-4835

[3]

Low frequency of CHEK2 1100delC allele in Australian multiple-case breast cancer families:: functional analysis in heterozygous individuals [J].

Jekimovs, CR ;

Chen, X ;

Arnold, J ;

Gatei, M ;

Richard, DJ ;

Spurdle, AB ;

Khanna, KK ;

Chenevix-Trench, G .

BRITISH JOURNAL OF CANCER, 2005, 92 (04) :784-790

[4]

Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients [J].

Kilpivaara, O ;

Bartkova, J ;

Eerola, A ;

Syrjäkoski, K ;

Vahteristo, P ;

Lukas, J ;

Blomqvist, C ;

Holli, K ;

Heikkilä, P ;

Sauter, G ;

Niemi, OPKI ;

Bartek, J ;

Nevanlinna, H .

INTERNATIONAL JOURNAL OF CANCER, 2005, 113 (04) :575-580

[5]

Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations [J].

Meijers-Heijboer, H ;

van den Ouweland, A ;

Klijn, J ;

Wasielewski, M ;

de Snoo, A ;

Oldenburg, R ;

Hollestelle, A ;

Houben, M ;

Crepin, E ;

van Veghel-Plandsoen, M ;

Elstrodt, F ;

van Duijn, C ;

Bartels, C ;

Meijers, C ;

Schutte, M ;

McGuffog, L ;

Thompson, D ;

Easton, DF ;

Sodha, N ;

Seal, S ;

Barfoot, R ;

Mangion, J ;

Chang-Claude, J ;

Eccles, D ;

Eeles, R ;

Evans, DG ;

Houlston, R ;

Murday, V ;

Narod, S ;

Peretz, T ;

Peto, J ;

Phelan, C ;

Zhang, HX ;

Szabo, C ;

Devilee, P ;

Goldgar, D ;

Futreal, PA ;

Nathanson, KL ;

Weber, BL ;

Rahman, N ;

Stratton, MR .

NATURE GENETICS, 2002, 31 (01) :55-59

[6]

Offit K., 2003, BMC MED GENET, V4, P1, DOI DOI 10.1186/1471-2350-4-1

[7]

The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population [J].

Osorio, A ;

Rodríguez-López, R ;

Díez, O ;

de la Hoya, M ;

Martínez, JI ;

Vega, A ;

Esteban-Cardeñosa, E ;

Alonso, C ;

Caldés, T ;

Benítez, J .

INTERNATIONAL JOURNAL OF CANCER, 2004, 108 (01) :54-56

[8]

German populations with infrequent CHEK2*1100delC and minor associations with early-onset and familial breast cancer [J].

Rashid, MU ;

Jakubowska, A ;

Justenhoven, C ;

Harth, V ;

Pesch, B ;

Baisch, C ;

Pierl, CB ;

Brüning, T ;

Ko, Y ;

Benner, A ;

Wichmann, HE ;

Rauch, H ;

Hamann, U .

EUROPEAN JOURNAL OF CANCER, 2005, 41 (18) :2896-2903

[9]

Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation [J].

Schmidt, Marjanka K. ;

Tollenaar, Rob A. E. M. ;

de Kemp, Sanne R. ;

Broeks, Annegien ;

Cornelisse, Cees J. ;

Smit, Vincent T. H. B. M. ;

Peterse, Johannes L. ;

van Leeuwen, Flora E. ;

Van't Veer, Laura J. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (01) :64-69

[10]

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer [J].

Walsh, T ;

Casadei, S ;

Coats, KH ;

Swisher, E ;

Stray, SM ;

Higgins, J ;

Roach, KC ;

Mandell, J ;

Lee, MK ;

Ciernikova, S ;

Foretova, L ;

Soucek, P ;

King, MC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (12) :1379-1388

← 1 2 →